Galapagos NV
GLPG
#4572
Rank
โ‚น191.69 B
Marketcap
โ‚น2,909
Share price
0.37%
Change (1 day)
26.42%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -โ‚น34.67

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -โ‚น30.37. In 2024 the company made an earnings per share (EPS) of โ‚น104.39 a decrease over its 2023 EPS that were of โ‚น317.82.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น34.67-133.21%
2024โ‚น104.39-67.16%
2023โ‚น317.82-199.64%
2022-โ‚น318.9699.03%
2021-โ‚น160.26-68.98%
2020-โ‚น516.66-298.06%
2019โ‚น260.86-554.64%
2018-โ‚น57.38-77.18%
2017-โ‚น251.47-326.21%
2016โ‚น111.17-134.19%
2015-โ‚น325.12-371.34%
2014โ‚น119.82-445.98%
2013-โ‚น34.6332.88%
2012-โ‚น26.06-82.07%
2011-โ‚น145.39-817.9%
2010โ‚น20.2512.73%
2009โ‚น17.96-120.79%
2008-โ‚น86.39-37.67%
2007-โ‚น138.6239.64%
2006-โ‚น99.2728.17%
2005-โ‚น77.456.25%
2004-โ‚น72.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
AstraZeneca
AZN
โ‚น271.83-994.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚น934.99-3,178.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น331.90-1,192.75%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
โ‚น121.08-498.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-โ‚น54.63 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น721.62-2,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น56.43-285.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚น322.07-1,160.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น680.13-2,339.29%๐Ÿ‡บ๐Ÿ‡ธ USA